Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
CorMedix Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 7.75 · opened flat. High/low 7.83 at 12:30 pm ET, 7.74 at 9:45 am ET.
195 institutional managers report a position in CorMedix Inc. worth $359.8M between them, filed on form 13F for the quarter ending 2026-06-30. 27 of them hold 80% of it, the largest being BlackRock, Inc. at 13.80%.
170 more managers in the register
27 managers hold 80% of the $359.8M institutional base. The other 168 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
CRMD (CorMedix Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via Deep Track Capital, LP, Alyeska Investment Group, L.P., Marshall Wace LLP +1 more · 13.69% of CRMD, 19.37% of ALGS
via Deep Track Capital, LP, Marshall Wace LLP, Trexquant Investment LP +3 more · 13.69% of CRMD, 12.58% of CMPS
via Deep Track Capital, LP, Marshall Wace LLP, Hennion & Walsh Asset Management, Inc. +1 more · 13.69% of CRMD, 12.56% of ALT
via Deep Track Capital, LP, Alyeska Investment Group, L.P., Balyasny Asset Management LLC · 13.69% of CRMD, 11.26% of LBRX
via Deep Track Capital, LP, Wellington Management Group LLP · 13.69% of CRMD, 13.05% of PMN
via Deep Track Capital, LP, Marshall Wace LLP · 13.69% of CRMD, 11.84% of CNTX
Managers holding a meaningful stake in CRMD also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.